Disclosures for "Safety and Tolerability of Intravenous Immunoglobulin Infusion in Down Syndrome Regression Disorder"
-
Dr. Santoro has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Santoro has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cycle Pharma.
-
Dr. Jafarpour has nothing to disclose.
-
Dr. Khoshnood has nothing to disclose.
-
Ms. Boyd has nothing to disclose.
-
Mr. Vogel has nothing to disclose.
-
Mrs. Nguyen has nothing to disclose.
-
Dr. Rafii has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immune. Dr. Rafii has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Keystone Bio. Dr. Rafii has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alzheon.